Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950129-03-005675
Filing Date
2003-11-14
Accepted
2003-11-14 14:19:10
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ENCYSIVE PHARMACEUTICALS INC.- AMEND.- 12/31/2003 h10673e10vkza.txt 10-K/A 348427
3 CONSENT OF KPMG LLP, SEATTLE, WASHINGTON h10673exv23w1.txt EX-23.1 1747
4 CONSENT OF KPMG LLP, HOUSTON, TEXAS h10673exv23w2.txt EX-23.2 1093
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 h10673exv31w1.txt EX-31.1 3444
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 h10673exv31w2.txt EX-31.2 3467
7 CERTIFICATION OF CEO PURSUANT TO SECTION 906 h10673exv32w1.txt EX-32.1 1453
8 CERTIFICATION OF CFO PURSUANT TO SECTION 906 h10673exv32w2.txt EX-32.2 1509
  Complete submission text file 0000950129-03-005675.txt   363576
Mailing Address
Business Address 6700 WEST LOOP SOUTH 4TH FLOOR BELLAIRE TX 77401 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20117 | Film No.: 031003119
SIC: 2834 Pharmaceutical Preparations